Macalisang, Roel E.
HRN: 21-29-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2022
MUPIROCIN 2%, 15G (TUBE)
05/05/2022
05/12/2022
TOPICAL
Apply Thinly To Affected Areas
Bid
Multiple Abrasions
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes